Pillstats
Rx only · Tablet, Extended Release · Oral

Bupropion Hydrochloride

Brands: Wellbutrin Xl · Bupropion · Bupropion Hydrochloride

38 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US144 NDCs
38 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)42347
US makers39 labelers
Packages426
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 101 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.030$0.059$0.089$0.119Dec 2025Apr 2026Jul 2026
$0.091
Latest avg · Jul 22, 2026
-12%
Since Dec 17, 2025
38
Active US suppliers
30%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

722K1.4M2.2M2.9M2025 Q12025 Q22025 Q32025 Q42026 Q1
2.0M
Rx · 2026 Q1
85.7M
Units dispensed
-22%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it38 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager94SUPPLYING
A-S Medication Solutionsunknown33SUPPLYING
Proficient Rx LPunknown32SUPPLYING
Epic Pharma, LLCunknown29SUPPLYING
Preferred Pharmaceuticals Inc.unknown25SUPPLYING
Camber Pharmaceuticals, Inc.unknown18SUPPLYING
Cipla USA Inc.unknown17SUPPLYING
Slate Run Pharmaceuticals, LLCunknown16SUPPLYING
REMEDYREPACK INC.repackager15SUPPLYING
Rising Pharma Holdings, Inc.unknown9SUPPLYING
Vitruvias Therapeuticsunknown8SUPPLYING
Mullan Pharmaceutical Inc.unknown8SUPPLYING
Lannett Company, Inc.unknown8SUPPLYING
Direct_Rxunknown8SUPPLYING
Northwind Health Company, LLCunknown7SUPPLYING

+ 24 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Sep 15, 2025
    RECALLRecall (Class II): Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmace…

    Failed Tablet/Capsule Specifications — Recalling firm: Graviti Pharmaceuticals Private Limited — Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.

  • Jun 24, 2024
    RECALLRecall (Class II): buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only…

    Failed Dissolution Specifications; the product is dissolving faster than the specified limits. — Recalling firm: Amerisource Health Services LLC — Nationwide in the USA

  • Dec 29, 2023
    RECALLRecall (Class II): buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising P…

    Presence of Foreign Tablets/Capsules — Recalling firm: Rising Pharma Holding, Inc. — Nationwide within the United States

  • Sep 6, 2018
    RECALLRecall (Class III): Bupropion Hydrochloride ER Tablets, USP 150 mg, packaged in a) 90-count bottle (NDC 69097-875-05), Manufactured for: Ci…

    Failed impurities/ degradation specifications: Out-of-specification results were observed in the meta-chlorobenzoic acid impurity in batches 18 months or older from date of manufacture in the 90 count bottle size. — Recalling firm: InvaGen Pharmaceuticals, Inc. — Product was distributed to 14 major distributors who shipped the product U.S.A. nationwide.

  • Mar 15, 2018
    RECALLRecall (Class III): buPROPion HCl Extended-Release Tablets, USP (SR), 150 mg ,a) 60 count (NDC 69097-878-03) and b) 100 count (NDC 69097…

    Failed Dissolution Specifications; during stability testing — Recalling firm: InvaGen Pharmaceuticals, Inc. — Nationwide

  • Mar 15, 2018
    RECALLRecall (Class III): buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: Cipla USA Inc.…

    Failed Dissolution Specifications; during stability testing — Recalling firm: InvaGen Pharmaceuticals, Inc. — Nationwide